−202.6266USD
−58.65 MUSD
About KINARUS THERAPEUTICS HOLDING AG
Sector
CEO
Roland Rutschmann
Headquarters
Liestal
Website
ISIN
CH1330780979
FIGI
BBG000BGX6H3
Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KNRS is 16.1280 USD — it has decreased by 5.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange KINARUS THERAPEUTICS HOLDING AG stocks are traded under the ticker KNRS.
KNRS stock is 11.76% volatile and has beta coefficient of 0.23. Check out the list of the most volatile stocks — is KINARUS THERAPEUTICS HOLDING AG there?
Yes, you can track KINARUS THERAPEUTICS HOLDING AG financials in yearly and quarterly reports right on TradingView.
KNRS stock has risen by 5.88% compared to the previous week, the month change is a 21.74% fall, over the last year KINARUS THERAPEUTICS HOLDING AG has showed a 67.27% decrease.
KNRS net income for the last quarter is −56.21 M USD, while the quarter before that showed −2.29 M USD of net income which accounts for −2.35 K% change. Track more KINARUS THERAPEUTICS HOLDING AG financial stats to get the full picture.
No, KNRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KNRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KINARUS THERAPEUTICS HOLDING AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KINARUS THERAPEUTICS HOLDING AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KINARUS THERAPEUTICS HOLDING AG stock shows the sell signal. See more of KINARUS THERAPEUTICS HOLDING AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.